Medifast Inc (MED)
Household and Personal Products • Consumer Staples
August 03, 2026 Medifast Inc. Reports Second Quarter 2026 Financial Results Medifast Inc. faced a tough second quarter in 2026, reporting a 27.6% revenue drop and a net loss. Despite these challenges, executives emphasize potential recovery through innovative product launches and a strong cash position.
August 03, 2026 Medifast Inc. Reports 2026 Q2 Results: Strategic Transformation Amid Challenges Medifast, Inc. faced a significant revenue decline in Q2 2026, largely due to reduced active earning coaches. The company's strategic pivot towards metabolic health, including the launch of its Trilivy product line, aims to address these challenges as it adapts to market dynamics.
July 20, 2026 Medifast Inc. Set to Reveal Q2 Financial Results on August 3, 2026 Medifast Inc. is set to release its Q2 financial results on August 3, 2026, followed by a conference call featuring CEO Nick Johnson and CFO Jim Maloney. The company, known for its metabolic health solutions like Trilivy, aims to provide insights into its performance and future strategies.
July 17, 2026 Medifast Inc. Launches Trilivy: A Comprehensive Approach to Metabolic Health Medifast Inc. launched Trilivy, a comprehensive metabolic health system aimed at addressing metabolic dysfunction in U.S. adults. With innovative technologies like MetaVantage, Trilivy offers a structured approach to weight loss and wellness through personalized coaching and community support.
May 26, 2026 Medifast Inc. Appoints Nicholas Johnson as New CEO Medifast Inc. has appointed Nicholas Johnson as its new CEO effective June 1, 2026, following Dan Chard's transition to Chairman of the Board. Johnson aims to enhance the company's focus on metabolic health and leverage its unique coach-led model to drive growth and innovation.
May 04, 2026 Medifast Inc. Reports Q1 2026 Financial Results: A Period of Transition and Challenges Medifast Inc. reported a 34.3% revenue decline in Q1 2026, primarily due to fewer active coaches. Despite challenges, the company emphasizes innovations like Metabolic Synchronization to enhance its coaching model and address metabolic dysfunction.
May 04, 2026 Medifast Reports First Quarter 2026 Financial Results: A Mixed Bag Amidst Strategic Transformation Medifast's Q1 2026 results show a 34.3% revenue decline and a net loss of $2.1 million, attributed to fewer active coaches. CEO Dan Chard remains optimistic about the company's metabolic health strategy, despite ongoing operational challenges.
April 20, 2026 Medifast Inc. Prepares to Announce Q1 2026 Financial Results Medifast Inc. will announce its Q1 2026 financial results on May 4, followed by a conference call with key executives. The company continues to lead in metabolic health with innovative solutions like Metabolic Synchronization®.
March 20, 2026 Medifast Inc. Enters Cooperation Agreement with Steamboat Capital Medifast, Inc. has entered a Cooperation Agreement with Steamboat Capital, nominating Parsa Kiai and Jeff Rose as independent directors. The company aims to improve governance and profitability while transitioning leadership roles.
February 20, 2026 Medifast Inc. Announces Reimbursement for OPTAVIA® Metabolic Health System Medifast Inc. has announced that its OPTAVIA® program is now eligible for reimbursement through select insurance plans, potentially saving clients up to 40%. This initiative aims to combat the high rates of metabolic dysfunction in the U.S. by providing a science-backed system and personalized coaching.
February 17, 2026 Medifast Inc. Reports Fourth Quarter and Full Year 2025 Financial Results Medifast Inc. reported significant revenue declines and a net loss for Q4 and the full year 2025, largely due to a drop in active earning coaches. CEO Dan Chard outlined a new strategic focus on metabolic health and revenue guidance for 2026, aiming for a turnaround amid the challenges faced.
February 17, 2026 Medifast Inc. Reports Significant Financial Challenges in 2025 In 2025, Medifast Inc. reported a significant revenue decline of 36%, attributed to a 40.6% drop in active earning coaches. Despite cost reductions, the company faced operational losses and is now focusing on growth initiatives and innovation to combat market challenges.
February 03, 2026 Medifast Inc. Set to Reveal Fourth Quarter and Full Year Financial Results Medifast Inc. is set to announce its fourth quarter and full-year financial results on February 17, 2026. The company will host a conference call at 4:30 PM ET to discuss the findings, featuring key executives. Stakeholders are eager for insights into Medifast’s performance and strategic direction.
January 16, 2026 Medifast Inc. Highlights Tiffany Howard's Transformative Journey with OPTAVIA® Tiffany Howard's remarkable transformation with the OPTAVIA program showcases how personalized coaching and community support can overcome metabolic health challenges. Her story emphasizes the effectiveness of sustainable habit-building strategies to achieve lasting health improvements.
January 15, 2026 Medifast Inc. Launches New Docuseries Episode Highlighting Metabolic Health in Spain Medifast Inc. launched a docuseries episode titled *'Health by Design: Spain'* focusing on metabolic health and longevity in Galicia. Hosted by Dr. Wayne Andersen, the episode emphasizes community support, active lifestyles, and the importance of routine for improved well-being.
January 05, 2026 Medifast Inc. Announces Leadership Transition Amidst Strategic Evolution Medifast, Inc. has announced a leadership transition, with Dan Chard stepping down as CEO in June 2026. Nicholas Johnson, the Chief Field Operations Officer, takes over as President and is poised to lead the company towards its goal of becoming a leader in metabolic health.
December 09, 2025 Medifast Inc. Press Release Highlights Critical Awareness Gap in Metabolic Health A new survey by Medifast's OPTAVIA reveals a significant lack of awareness about metabolic health among Americans, with 80% struggling to understand its importance. The findings highlight a critical need for education, as many individuals expressed motivation to improve their health when informed. Medifast aims to bridge this gap through its Metabolic Synchronization™ strategy.
November 13, 2025 Medifast Inc. Showcases Pioneering Research at ObesityWeek Conference At ObesityWeek 2025, Medifast presented pivotal research on obesity management, revealing challenges with anti-obesity medications and the critical role of sleep in metabolic health. This aligns with their strategic approach to tackle metabolic dysfunction through innovative solutions.
November 03, 2025 Medifast Reports Dismal Third Quarter 2025 Financial Results Amid Strategic Shift Medifast Inc. reported a 36.2% revenue decline in Q3 2025, transitioning from a weight-loss focus to promoting metabolic health. Despite financial setbacks, the company maintains a strong balance sheet.
November 03, 2025 Medifast Inc. Reports Q3 2025 Financial Results: A Challenging Quarter Amid Strategic Transformation Medifast Inc. faced a challenging Q3 2025, with a 36.2% decline in revenue and a significant reduction in active coaches. Despite these hurdles, the company is focusing on strategic initiatives to enhance metabolic health and foster growth in a competitive market.
October 27, 2025 Medifast Inc. Shifts Focus to Metabolic Health with Innovative Metabolic Synchronization™ Medifast Inc. is launching its Metabolic Synchronization™ program to enhance metabolic health amid rising obesity rates. This innovative approach targets visceral fat, preserves lean mass, and supports muscle health, offering new solutions for individuals at various health stages.
October 21, 2025 Medifast to Reveal Third Quarter Financial Results on November 3, 2025 Medifast Inc. will reveal its third-quarter financial results on November 3, 2025, followed by a conference call at 4:30 PM ET. Investors can access the call online or by phone for insights into the company's performance and future outlook.
September 15, 2025 Medifast Inc. Reinforces Commitment to Metabolic Health with Groundbreaking Findings Medifast Inc. is taking significant steps to combat the metabolic health crisis in the U.S. with its 5 & 1 Plan, which has shown to preserve 98% of lean mass in users. With over 40 years of research backing its initiatives, Medifast aims to improve health outcomes and quality of life for those struggling with metabolic dysfunction.
August 04, 2025 Medifast Inc. Reports Q2 2025 Results: Navigating Challenges in the Weight-Loss Industry Medifast Inc. reported a revenue decline in Q2 2025, driven by a decrease in active coaches and challenges from GLP-1 medications. Despite a net income improvement, the company faces macroeconomic pressures and competitive challenges. Strategic initiatives aim to enhance client acquisition and support for coaches.
April 28, 2025 Medifast Inc. Reports Significant Revenue Decline in Q1 2025 Amid Market Transformation Medifast Inc. faced a significant revenue decline of 33.8% in Q1 2025, primarily due to fewer active OPTAVIA coaches and increased competition from GLP-1 weight loss medications. The company is adapting with new nutrition plans and cost management strategies to navigate market challenges.
April 28, 2025 Medifast Inc Reports Disappointing First Quarter 2025 Financial Results Medifast Inc. reported a disappointing 33.8% decline in revenue for Q1 2025, primarily due to a drop in active OPTAVIA coaches. Despite a strong balance sheet, the company faces challenges in maintaining profitability as it looks to revitalize its coaching network and improve customer support.
April 14, 2025 Medifast Inc. Set to Announce First Quarter Financial Results Medifast Inc. is set to release its first quarter financial results on April 28, 2025. Key executives will discuss the company's strategic direction during a conference call, providing insights into their health and wellness initiatives.
February 18, 2025 Medifast Inc. Reports Significant Revenue Decline in 2024 Annual Report Medifast Inc. faced a challenging year in 2024, reporting a 43.8% decline in revenue to $602.5 million, primarily due to reduced productivity and participation of its OPTAVIA coaches. The company is exploring strategies to revitalize coach engagement as it navigates financial difficulties and a changing market landscape.
February 18, 2025 Medifast Inc. Releases Fourth Quarter and Full Year 2024 Financial Results In Q4 2024, Medifast Inc. faced significant revenue declines, reporting $119 million, down 37.7% year-over-year. Despite challenges, the company aims for a strategic recovery in 2025, focusing on enhancing coach productivity and expanding its network.
February 14, 2025 SWOT Analysis of Medifast Inc in 2025 This SWOT analysis of Medifast Inc. examines its strategic position in the weight management industry for 2025. It highlights the company's strong brand and innovative offerings while addressing challenges such as competition and economic vulnerabilities.
November 04, 2024 Medifast Inc. Reports Q3 2024 Results: A Period of Challenges and Transformation Medifast Inc. reported a significant 40.6% drop in revenue for Q3 2024, driven by fewer OPTAVIA coaches and declining productivity. In response, the company is implementing transformative strategies, including a partnership with LifeMD and new marketing campaigns to attract customers and navigate market challenges.
August 05, 2024 Medifast Inc. Reports Significant Decline in Q2 2024 Financial Results Medifast Inc. experienced a significant decline in Q2 2024, with a 43.1% drop in revenue compared to the previous year, largely due to fewer active OPTAVIA Coaches. The company is launching new initiatives to combat market challenges and aims for a turnaround in the latter half of 2024.
April 29, 2024 Medifast Inc. Reports Q1 2024 Financial Results: A Period of Transition and Transformation Medifast Inc. reported a notable decline in Q1 2024 financial metrics, with revenue down 49.9% year-over-year. Despite challenges, the company is implementing strategic initiatives to transform its business model and enhance market presence, focusing on sports nutrition and digital engagement.